|
Volumn 65, Issue 2, 2013, Pages 91-93
|
[Increases in pharmaceutical expenditures of PHI by monoclonal antibodies].;Ausgabensteigerungen im Arzneimittelbereich der PKV durch monoklonale Antikörper.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MONOCLONAL ANTIBODY;
ARTICLE;
ECONOMICS;
GERMANY;
HEALTH CARE COST;
HUMAN;
ORGANIZATION AND MANAGEMENT;
PRESCRIPTION;
REIMBURSEMENT;
STATISTICS;
UTILIZATION REVIEW;
ANTIBODIES, MONOCLONAL;
GERMANY;
HEALTH EXPENDITURES;
HUMANS;
INSURANCE, HEALTH, REIMBURSEMENT;
PRESCRIPTIONS;
PRIVATE SECTOR;
|
EID: 84883850607
PISSN: 09334548
EISSN: None
Source Type: None
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|